We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF
SBIO

66 hedge funds and large institutions have $67.5M invested in ALPS Medical Breakthroughs ETF in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 23 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

10% more funds holding

Funds holding: 60 → 66 (+6)

1.99% more ownership

Funds ownership: 35.39% → 37.38% (+2%)

6% less capital invested

Capital invested by funds: $71.7M → $67.5M (-$4.16M)

61% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 23

Holders
66
Holders Change
+6
Holders Change %
+10%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
9
Reduced
23
Closed
4
Calls
$1.54M
Puts
–
Net Calls
+$1.54M
Net Calls Change
+$368K

Top Buyers

Rank Fund Capital Flow
1
MC
Matisse Capital
Oregon
+$5.99M
2
SFS
Strategic Financial Services
New York
+$674K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$522K
4
EWA
Exencial Wealth Advisors
Oklahoma
+$487K
5
Wells Fargo
Wells Fargo
California
+$481K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$1.08M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$921K
3
MML Investors Services
MML Investors Services
Massachusetts
-$644K
4
Stifel Financial
Stifel Financial
Missouri
-$586K
5
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$304K
Name Holding Trade Value Shares
Change 		Change in
Stake
GAM
26
Griffin Asset Management
New York
$385K – – –
Cetera Investment Advisers
27
Cetera Investment Advisers
Illinois
$369K -$187K -4,199 -32%
Stifel Financial
28
Stifel Financial
Missouri
$297K -$586K -13,159 -65%
SWP
29
Stratos Wealth Partners
Ohio
$272K +$13.8K +309 +5%
CCC
30
Crescent Capital Consulting
Louisiana
$253K – – –
GIA
31
Gladstone Institutional Advisory
Florida
$208K +$219K +4,924 New
UCFA
32
United Capital Financial Advisors
Texas
$207K -$8.91K -200 -4%
William Blair & Company
33
William Blair & Company
Illinois
$162K – – –
RPCONE
34
Retirement Planning Company of New England
Rhode Island
$140K +$149K +3,338 New
CT
35
Cambridge Trust
Massachusetts
$138K +$146K +3,278 New
AWM
36
AllSquare Wealth Management
New York
$134K – – –
VNA
37
Valley National Advisers
Pennsylvania
$126K -$57.3K -1,285 -30%
KPCM
38
Kings Point Capital Management
New York
$67K – – –
CG
39
Cutler Group
California
$63K +$13.4K +300 +25%
US Bancorp
40
US Bancorp
Minnesota
$42K – – –
EWM
41
Elmwood Wealth Management
California
$42K +$44.6K +1,000 New
Northwestern Mutual Wealth Management
42
Northwestern Mutual Wealth Management
Wisconsin
$41K -$52.9K -1,186 -55%
S
43
SignatureFD
Georgia
$17K – – –
HWM
44
HighMark Wealth Management
Minnesota
$17K +$17.8K +400 New
LWANC
45
Laurel Wealth Advisors (North Carolina)
North Carolina
$16K – – –
APA
46
American Portfolios Advisors
New York
$14.4K – – –
OC
47
Oakworth Capital
Alabama
$13K – – –
TWM
48
Tradition Wealth Management
Minnesota
$13K – – –
First Manhattan
49
First Manhattan
New York
$12K -$4.46K -100 -25%
TFS
50
TrustCore Financial Services
Tennessee
$10K – – –
1
2
3

SBIO Hedge Fund Activity: Q4 2021 in Review

66 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2021, worth a combined $67.5M — down 5.8% from $71.7M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new SBIO positions and 4 closed out — a net gain of 7 holders — while 9 added to existing stakes and 23 trimmed.

The largest buyer was Matisse Capital, adding an estimated $5.99M. The largest seller was Bank of America, cutting an estimated $1.08M.

  • 66 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2021, up from 60 in Q3 2021.
  • Funds reported $67.5M of ALPS Medical Breakthroughs ETF stock for Q4 2021, down 5.8% quarter-over-quarter.
  • 11 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2021 and 4 closed out, a net change of +7 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q4 2021 was Matisse Capital, an estimated $5.99M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q4 2021 was Bank of America, an estimated $1.08M sold.

Based on aggregated 13F filings for Q4 2021.